Observational (n=1,946)
Yes
The SOURCE 3 registry demonstrates 1-year outcomes for the latest generation balloon-expandable TAVI valve, with 12.6% all-cause mortality and 13.2% new pacemaker rate.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Thomas F. Lüscher (2017) conducted an observational in Aortic stenosis (n=1,946). Transcatheter aortic valve implantation (Edwards SAPIEN 3) was evaluated on All-cause mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: